Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 7, 2014, Pages 1012-1020

  Grammatikos, Georgios ^a,b   Mühle, Christiane ^c   Ferreiros, Nerea ^b   Schroeter, Sirkka ^a,b   Bogdanou, Dimitra ^b   Schwalm, Stephanie ^a   Hintereder, Gudrun ^b   Kornhuber, Johannes ^c   Zeuzem, Stefan ^b   Sarrazin, Christoph ^b   Pfeilschifter, Josef ^a  

^a Pharmazentrum Frankfurt   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

ASM; Ceramide; HCV; NAFLD; S1P; Sphingosine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CERAMIDE DERIVATIVE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NONALCOHOLIC FATTY LIVER; NORMAL VALUE; PRIORITY JOURNAL; SPECTROFLUOROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ASM; CERAMIDE; HCV; NAFLD; S1P; SPHINGOSINE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CERAMIDES; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

EID: 84899790279     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.04.007     Document Type: Article

References (53)

1. T. Kolter A view on sphingolipids and disease Chem. Phys. Lipids 164 2011 590 606
2. S.M. Hammad Blood sphingolipids in homeostasis and pathobiology Adv. Exp. Med. Biol. 721 2011 57 66
3. W.L. Holland, and S.A. Summers Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism Endocr. Rev. 29 2008 381 402
4. M. Mari, and J.C. Fernandez-Checa Sphingolipid signalling and liver diseases Liver Int. 27 2007 440 450
5. L. Longato, M. Tong, J.R. Wands, and S.M. de la Monte High fat diet induced hepatic steatosis and insulin resistance: role of dysregulated ceramide metabolism Hepatol. Res. 42 2012 412 427
6. M. Pagadala, T. Kasumov, A.J. McCullough, N.N. Zein, and J.P. Kirwan Role of ceramides in nonalcoholic fatty liver disease Trends Endocrinol. Metab. 23 2012 365 371
7. H. Zhao, M. Przybylska, I.H. Wu, J. Zhang, P. Maniatis, J. Pacheco, P. Piepenhagen, D. Copeland, C. Arbeeny, J.A. Shayman, J.M. Aerts, C. Jiang, S.H. Cheng, and N.S. Yew Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice Hepatology 50 2009 85 93
8. B.T. Bikman, and S.A. Summers Sphingolipids and hepatic steatosis Adv. Exp. Med. Biol. 721 2011 87 97
9. H. Aizaki, K.J. Lee, V.M. Sung, H. Ishiko, and M.M. Lai Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts Virology 324 2004 450 461
10. H. Aizaki, K. Morikawa, M. Fukasawa, H. Hara, Y. Inoue, H. Tani, K. Saito, M. Nishijima, K. Hanada, Y. Matsuura, M.M. Lai, T. Miyamura, T. Wakita, and T. Suzuki Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection J. Virol. 82 2008 5715 5724
11. Y. Hirata, K. Ikeda, M. Sudoh, Y. Tokunaga, A. Suzuki, L. Weng, M. Ohta, Y. Tobita, K. Okano, K. Ozeki, K. Kawasaki, T. Tsukuda, A. Katsume, Y. Aoki, T. Umehara, S. Sekiguchi, T. Toyoda, K. Shimotohno, T. Soga, M. Nishijima, R. Taguchi, and M. Kohara Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis PLoS Pathog. 8 2012 e1002860
12. C. Voisset, M. Lavie, F. Helle, B.A. Op De, A. Bilheu, J. Bertrand-Michel, F. Terce, L. Cocquerel, C. Wychowski, N. Vu-Dac, and J. Dubuisson Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry Cell. Microbiol. 10 2008 606 617
13. H. Sakamoto, K. Okamoto, M. Aoki, H. Kato, A. Katsume, A. Ohta, T. Tsukuda, N. Shimma, Y. Aoki, M. Arisawa, M. Kohara, and M. Sudoh Host sphingolipid biosynthesis as a target for hepatitis C virus therapy Nat. Chem. Biol. 1 2005 333 337
14. E. Gulbins, and P.L. Li Physiological and pathophysiological aspects of ceramide Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 R11 R26
15. J.M. Gill, and N. Sattar Ceramides: a new player in the inflammation-insulin resistance paradigm? Diabetologia 52 2009 2475 2477
16. R.N. Kolesnick, F.M. Goni, and A. Alonso Compartmentalization of ceramide signaling: physical foundations and biological effects J. Cell. Physiol. 184 2000 285 300
17. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
18. L. Weng, Y. Hirata, M. Arai, M. Kohara, T. Wakita, K. Watashi, K. Shimotohno, Y. He, J. Zhong, and T. Toyoda Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner J. Virol. 84 2010 11761 11770
19. P.A. Lang, M. Schenck, J.P. Nicolay, J.U. Becker, D.S. Kempe, A. Lupescu, S. Koka, K. Eisele, B.A. Klarl, H. Rubben, K.W. Schmid, K. Mann, S. Hildenbrand, H. Hefter, S.M. Huber, T. Wieder, A. Erhardt, D. Haussinger, E. Gulbins, and F. Lang Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide Nat. Med. 13 2007 164 170
20. J.M. Schattenberg, P.R. Galle, and M. Schuchmann Apoptosis in liver disease Liver Int. 26 2006 904 911
21. P.Y. Ke, and S.S. Chen Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases Viruses 4 2012 2251 2290
22. D.G. Tiniakos, M.B. Vos, and E.M. Brunt Nonalcoholic fatty liver disease: pathology and pathogenesis Annu. Rev. Pathol. 5 2010 145 171
23. M.M. Mielke, V.V. Bandaru, N.J. Haughey, J. Xia, L.P. Fried, S. Yasar, M. Albert, V. Varma, G. Harris, E.B. Schneider, P.V. Rabins, K. Bandeen-Roche, C.G. Lyketsos, and M.C. Carlson Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II Neurology 79 2012 633 641
24. J.M. Haus, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, R.A. Defronzo, and J.P. Kirwan Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 2009 337 343
25. S. Lightle, R. Tosheva, A. Lee, J. Queen-Baker, B. Boyanovsky, S. Shedlofsky, and M. Nikolova-Karakashian Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase Arch. Biochem. Biophys. 419 2003 120 128
26. J. Nunes, M. Naymark, L. Sauer, A. Muhammad, H. Keun, J. Sturge, J. Stebbing, J. Waxman, and D. Pchejetski Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection Br. J. Cancer 106 2012 909 915
27. S. Pyne, J. Edwards, J. Ohotski, and N.J. Pyne Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers Front. Oncol. 2 2012 168
28. J. Kornhuber, A. Medlin, S. Bleich, V. Jendrossek, A.W. Henkel, J. Wiltfang, and E. Gulbins High activity of acid sphingomyelinase in major depression J. Neural Transm. 112 2005 1583 1590
29. M. Reichel, E. Greiner, T. Richter-Schmidinger, O. Yedibela, P. Tripal, A. Jacobi, S. Bleich, E. Gulbins, and J. Kornhuber Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence Alcohol. Clin. Exp. Res. 34 2010 46 50
30. W. Doehner, A.C. Bunck, M. Rauchhaus, H.S. von, F.M. Brunkhorst, M. Cicoira, C. Tschope, P. Ponikowski, R.A. Claus, and S.D. Anker Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow Eur. Heart J. 28 2007 821 828
31. R.A. Claus, A.C. Bunck, C.L. Bockmeyer, F.M. Brunkhorst, W. Losche, R. Kinscherf, and H.P. Deigner Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis FASEB J. 19 2005 1719 1721
32. M. Gorska, E. Baranczuk, and A. Dobrzyn Secretory Zn2 +-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated Horm. Metab. Res. 35 2003 506 507
33. Y. Osawa, E. Seki, M. Adachi, A. Suetsugu, H. Ito, H. Moriwaki, M. Seishima, and M. Nagaki Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice Hepatology 51 2010 237 245
34. S. Kirschnek, F. Paris, M. Weller, H. Grassme, K. Ferlinz, A. Riehle, Z. Fuks, R. Kolesnick, and E. Gulbins CD95-mediated apoptosis in vivo involves acid sphingomyelinase J. Biol. Chem. 275 2000 27316 27323
35. Y. Osawa, A. Suetsugu, R. Matsushima-Nishiwaki, I. Yasuda, T. Saibara, H. Moriwaki, M. Seishima, and O. Kozawa Liver acid sphingomyelinase inhibits growth of metastatic colon cancer J. Clin. Invest. 123 2013 834 843
36. L. Llacuna, M. Mari, C. Garcia-Ruiz, J.C. Fernandez-Checa, and A. Morales Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury Hepatology 44 2006 561 572
37. C. Garcia-Ruiz, A. Colell, M. Mari, A. Morales, M. Calvo, C. Enrich, and J.C. Fernandez-Checa Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice J. Clin. Invest. 111 2003 197 208
38. N. Murata, K. Sato, J. Kon, H. Tomura, and F. Okajima Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay Anal. Biochem. 282 2000 115 120
39. E. Gulbins, and R. Kolesnick Acid sphingomyelinase-derived ceramide signaling in apoptosis Subcell. Biochem. 36 2002 229 244
40. E.L. Smith, and E.H. Schuchman The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases FASEB J. 22 2008 3419 3431
41. I. Tabas Secretory sphingomyelinase Chem. Phys. Lipids 102 1999 123 130
42. R.W. Jenkins, C.J. Clarke, J.T. Lucas Jr., M. Shabbir, B.X. Wu, F. Simbari, J. Mueller, Y.A. Hannun, J. Lazarchick, and K. Shirai Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis Am. J. Hematol. 88 2013 E265 E272
43. A. Fernandez, N. Matias, R. Fucho, V. Ribas, M.C. Von, N. Nuno, A. Baulies, L. Martinez, N. Tarrats, M. Mari, A. Colell, A. Morales, L. Dubuquoy, P. Mathurin, R. Bataller, J. Caballeria, M. Elena, J. Balsinde, N. Kaplowitz, C. Garcia-Ruiz, and J.C. Fernandez-Checa ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading J. Hepatol. 59 2013 805 813
44. A. Moles, N. Tarrats, A. Morales, M. Dominguez, R. Bataller, J. Caballeria, C. Garcia-Ruiz, J.C. Fernandez-Checa, and M. Mari Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis Am. J. Pathol. 177 2010 1214 1224
45. Y.H. Zeidan, and Y.A. Hannun Activation of acid sphingomyelinase by protein kinase Cdelta-mediated phosphorylation J. Biol. Chem. 282 2007 11549 11561
46. T. Langmann, C. Buechler, S. Ries, A. Schaeffler, C. Aslanidis, M. Schuierer, M. Weiler, K. Sandhoff, P.J. de Jong, and G. Schmitz Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation J. Lipid Res. 40 1999 870 880
47. Y. Nishimura-Sakurai, N. Sakamoto, K. Mogushi, S. Nagaie, M. Nakagawa, Y. Itsui, M. Tasaka-Fujita, Y. Onuki-Karakama, G. Suda, K. Mishima, M. Yamamoto, M. Ueyama, Y. Funaoka, T. Watanabe, S. Azuma, Y. Sekine-Osajima, S. Kakinuma, K. Tsuchiya, N. Enomoto, H. Tanaka, and M. Watanabe Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells J. Gastroenterol. 45 2010 523 536
48. B.A. Rasmussen, D.M. Breen, and T.K. Lam Lipid sensing in the gut, brain and liver Trends Endocrinol. Metab. 23 2012 49 55
49. J.P. Truman, M.M. Al Gadban, K.J. Smith, R.W. Jenkins, N. Mayroo, G. Virella, M.F. Lopes-Virella, A. Bielawska, Y.A. Hannun, and S.M. Hammad Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release Immunology 136 2012 30 45
50. I. Majumdar, and L.D. Mastrandrea Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome Endocrine 41 2012 442 449
51. K. Promrat, L. Longato, J.R. Wands, and S.M. de la Monte Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels Hepatol. Res. 41 2011 754 762
52. G.M. Deevska, K.A. Rozenova, N.V. Giltiay, M.A. Chambers, J. White, B.B. Boyanovsky, J. Wei, A. Daugherty, E.J. Smart, M.B. Reid, A.H. Merrill Jr., and M. Nikolova-Karakashian Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice J. Biol. Chem. 284 2009 8359 8368
53. G. Fabrias, J. Munoz-Olaya, F. Cingolani, P. Signorelli, J. Casas, V. Gagliostro, and R. Ghidoni Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena Prog. Lipid Res. 51 2012 82 94